Derrick Scoggins, APRN
Nurse Practitioner · Bowling Green, KYNPI 1053980540
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (52.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 34 manufacturers reported payments, led by Tandem Diabetes Care, Inc. at 52.8% of the total. 2025 is the largest year on record at $13,252, more than ten times the $360 reported in 2021. Among nurse practitioner clinicians in KY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 711 payments — averaging $34.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Tandem Diabetes Care, Inc.$13K
- Medtronic$2K
- Novo Nordisk$1K
- Lilly USA, LLC$1K
- Amgen$1K
- Bayer$728
- plus $6K from 28 others
What the payments were for
- Speaking & faculty fees$12,93852%
- Travel & lodging$7043%
- Food & beverage$11,12745%
- Education$500%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Tandem Diabetes Care, Inc. | 26 | $13,116 |
| Medtronic | 53 | $1,530 |
| Novo Nordisk | 106 | $1,320 |
| Lilly USA, LLC | 76 | $1,314 |
| Amgen(2 entities) | 78 | $1,214 |
| Bayer | 43 | $728 |
| Boehringer Ingelheim | 40 | $688 |
| Corcept Therapeutics | 34 | $636 |
| Novartis | 44 | $628 |
| Mannkind Corporation | 20 | $622 |
| Insulet Corporation | 24 | $348 |
| AstraZeneca(2 entities) | 19 | $325 |
| Sanofi-aventis U.S. LLC | 21 | $323 |
| Dexcom, Inc. | 19 | $241 |
| Xeris Pharmaceuticals, Inc. | 12 | $236 |
| Radius Health, Inc. | 13 | $219 |
| Amneal Pharmaceuticals LLC | 18 | $201 |
| Kyowa Kirin, Inc. | 8 | $162 |
| AbbVie | 9 | $156 |
| Amarin Pharma, Inc. | 8 | $136 |
| Recordati_rare_diseases_inc. | 6 | $113 |
| Merck | 6 | $85 |
| Kowa Pharmaceuticals America, Inc. | 4 | $67 |
| Amryt Pharma Holdings Ltd | 4 | $66 |
| Ultragenyx Pharmaceutical Inc. | 4 | $62 |
| BETA Bionics, Inc. | 4 | $61 |
| Ascensia Diabetes Care US Inc. | 3 | $53 |
| Chiesi USA, Inc. | 2 | $48 |
| Esperion Therapeutics, Inc. | 2 | $38 |
| Verity Pharmaceuticals Inc. | 1 | $19 |
| Pfizer | 1 | $19 |
| Amphastar Pharmaceuticals, Inc. | 1 | $17 |
| Halozyme Inc | 1 | $15 |
| Antares Pharma, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- t:slim X2 Insulin Pump with Control-IQ$12,938
- MINIMED 780G$605
- AFREZZA$249
- TEPEZZA$125
How this compares
$24,820 in reported general payments places this provider in the 95th percentile of 1,918 nurse practitioner providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 543 | $614,245 |
| MounjaroTirzepatide | 307 | $340,435 |
| JardianceEmpagliflozin | 324 | $306,562 |
| Omnipod 5 Dexg7g6 Pods (Gen 5)Insulin Pump Cart,auto,bt,g6/7 | 106 | $183,441 |
| TrulicityDulaglutide | 132 | $172,665 |
| Tresiba Flextouch U-200Insulin Degludec | 87 | $153,557 |
| FarxigaDapagliflozin Propanediol | 150 | $141,172 |
| Humulin R U-500Insulin Regular, Human | 35 | $94,008 |
| RybelsusSemaglutide | 73 | $90,057 |
| AfrezzaInsulin Regular, Human | 18 | $82,900 |
| JanuviaSitagliptin Phosphate | 68 | $82,488 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 383 | $71,327 |
| KerendiaFinerenone | 76 | $67,080 |
| Tresiba Flextouch U-100Insulin Degludec | 55 | $60,001 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 42 | $58,353 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus, Novolog, Fiasp | $1,320 | $747,459721 claims |
| Lilly USA, LLCMounjaro, Trulicity, Humalog, Insulin Lispro | $1,314 | $546,751615 claims |
| Boehringer IngelheimJardiance | $688 | $306,562324 claims |
| AstraZenecaFarxiga | $325 | $141,172150 claims |
| MerckJanuvia, Janumet Xr | $85 | $93,33780 claims |
| Mannkind CorporationAfrezza | $622 | $82,90018 claims |
| BayerKerendia | $728 | $67,08076 claims |
| Radius Health, Inc.Tymlos | $219 | $47,37014 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $201 | $6,415670 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,918 nurse practitioner providers in Kentucky.
Other nurse practitioner in Bowling Green
- Emily LangloisBowling Green$10K
- Rachael BradfordLexington$447K
- Tara MuddLouisville$243K
- Lee HaasLouisville$95K
- Ashley KnableLouisville$86K
- Christina BenningerLouisville$81K
- Courtney BowlingCampbellsville$47K
- Rebecca BraunerLouisville$40K
- Scott SeitzWinchester$34K
- Kristen KreinestEdgewood$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.